Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which nerve block wins the battle against Post-Spine surgery pain?

NCT ID NCT07750418

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study looks at two ultrasound-guided nerve blocks used to manage pain after lumbar spine surgery: the classic TLIP block and the QIP block. Adults aged 18-65 having elective lumbar discectomy will receive one of these blocks as part of their routine care. Researchers will track how much opioid pain medication is needed in the first 24 hours, when pain medication is first requested, pain scores at several time points, and any side effects. The goal is to see which block provides better pain relief and reduces opioid use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Two ultrasound-guided nerve blocks (TLIP and QIP) using bupivacaine, a local anesthetic
What this could lead to
If one block proves better, it could become the preferred method to reduce pain and opioid use after lumbar spine surgery.
What could go wrong
This is a small observational study, not randomized, so results may be influenced by patient differences. Blocks may not work equally for everyone and carry rare risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged 18-65 years, ASA physical status I-II, undergoing elective lumbar discectomy at up to two spinal levels under general anesthesia at Vezirköprü State Hospital, who receive either a classic TLIP block or a QIP block for postoperative analgesia as part of routine clinical practice.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18-65 years * ASA physical status I-II * Undergoing elective lumbar discectomy at up to two spinal levels under general anesthesia * Receiving classic TLIP block or QIP block for postoperative analgesia as part of routine clinical practice Exclusion Criteria: * Hypersensitivity or allergy to study medications * Coagulopathy * Infection at the injection site * Severe neurological deficit * Chronic opioid use * Advanced hepatic or renal failure * Obesity (BMI \>35 kg/m2) * Pregnancy * ASA physical status III-IV * Mental retardation * Inability to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lumbar disc herniation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Intervertebral Disc Displacement lumbar disk disease Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Vezirköprü State Hospital

    Vezirköprü, Samsun, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.